In this context it is interesting to note that TYK2, and also pan-JAK inhibitors, in our study are somewhat more effective in ALCL ALK− compared to ALK+ cell lines (Fig. 3a, b). This evidence concerns the gene TYK2 and anaplastic large cell lymphoma.